Haemophilia trials in Denmark
6 of 11 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleAn Observational Study to Learn More About How Well Damoctocog Alfa Pegol Works in Previously Treated Children With Hemophilia A
- Where
- Many Locations
- Age
- 7 years to 12 years
- People
- 40 worldwide
- Run by
- Bayer
See details and how to joinNCT07088458 - No phaseEnrolling by invitationAdverse Event Data Collection From the EUHASS Registry on Turoctocog Alfa Pegol
- Where
- Søborg
- People
- 50
- Run by
- Novo Nordisk A/S
See details and how to joinNCT04682145 - No phaseEnrolling by invitationA Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN
- Where
- Aarhus N
- People
- 60 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT03745924 - No phaseTaking peopleAn Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B
- Where
- Århus N
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- CSL Behring
See details and how to joinNCT06008938 - No phaseTaking peopleThe European Paediatric Network for Haemophilia Management ( PedNet Registry)
- Where
- Aarhus
- People
- 4,000 worldwide
- Run by
- PedNet Haemophilia Research Foundation
See details and how to joinNCT02979119 - Phase 2/3Enrolling by invitationLong-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)
- Where
- Copenhagen Oe
- Age
- 18 years and over
- People
- 56 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05962398 · EU 2023-503765-37-00